
Otsuka Holdings Co., Ltd.
OTSKY
Updated: 23/09/2026, 08:39:06
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
No summaries found.
- Share price
- $35.91
- Market cap
- $37.73B
- Exchange
- OTC
- Currency
- USD
- CEO
- Makoto Inoue
- Employees
- 37,758
- IPO date
- 03/08/2012
- Beta
- -0.053
- Last dividend
- $0.00
- Day range
- $35.41 – $36.71
- 52-week range
- $25.30 – $40.92
- 1-day performance
- 1.58%
- 1-year performance
- 41.94%
- Current drawdown (1Y)
- -12.24%
- CIK
- N/A
- CUSIP
- 689164101
- ISIN
- US6891641010
- Created
- 07/12/2025, 05:39:04
- Last update
- 23/09/2026, 08:39:06
Track Otsuka Holdings Co., Ltd. with an AI analyst
See which prediction-market events move OTSKY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
Seeking Alpha • STOCK • 10/04/2026, 21:51:45
Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha • STOCK • 19/02/2026, 14:36:43
Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
GlobeNewsWire • STOCK • 04/02/2026, 09:30:00